Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.

Pietrantonio F, Cotsoglou C, Fucà G, Lo Vullo S, Nichetti F, Milione M, Coppa J, Vaiani M, Alessi A, Prisciandaro M, Droz-Dit Busset M, Morano F, Corallo S, Lazzati S, Antista M, Mennitto A, Randon G, Raimondi A, Belfiore A, Padovano B, Perrone F, Mariani L, Di Bartolomeo M, de Braud F, Mazzaferro V.

Clin Colorectal Cancer. 2019 Mar;18(1):34-43.e6. doi: 10.1016/j.clcc.2018.11.004. Epub 2018 Nov 24.

PMID:
30558859
2.

Penile Metastases From Renal Cell Carcinoma: Pre and Postcontrast Sonographic Findings.

Gitto S, Vaiani M, Cascella T, Lanocita R.

Ultrasound Q. 2018 Dec;34(4):285-287. doi: 10.1097/RUQ.0000000000000347.

PMID:
29509578
3.

Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.

Spreafico C, Sposito C, Vaiani M, Cascella T, Bhoori S, Morosi C, Lanocita R, Romito R, Chiesa C, Maccauro M, Marchianò A, Mazzaferro V.

J Hepatol. 2018 Apr;68(4):724-732. doi: 10.1016/j.jhep.2017.12.026. Epub 2018 Jan 10.

4.

Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma.

Greco G, Cascella T, Facciorusso A, Nani R, Lanocita R, Morosi C, Vaiani M, Calareso G, Greco FG, Ragnanese A, Bongini MA, Marchianò AV, Mazzaferro V, Spreafico C.

World J Radiol. 2017 May 28;9(5):245-252. doi: 10.4329/wjr.v9.i5.245.

5.

Eleven-year management of prostate cancer patients on active surveillance: what have we learned?

Marenghi C, Alvisi MF, Palorini F, Avuzzi B, Badenchini F, Bedini N, Bellardita L, Biasoni D, Bosetti D, Casale A, Catanzaro M, Colecchia M, De Luca L, Donegani S, Dordoni P, Lanocita R, Maffezzini M, Magnani T, Menichetti J, Messina A, Morlino S, Paolini B, Rancati T, Stagni S, Tesone A, Torelli T, Tulli Baldoin E, Vaiani M, Villa S, Villa S, Zaffaroni N, Nicolai N, Salvioni R, Valdagni R.

Tumori. 2017 Sep 18;103(5):464-474. doi: 10.5301/tj.5000649. Epub 2017 Jun 14.

6.

Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.

Pietrantonio F, Di Bartolomeo M, Cotsoglou C, Mennitto A, Berenato R, Morano F, Coppa J, Perrone F, Iacovelli R, Milione M, Alessi A, Vaiani M, Bossi I, Ricchini F, Scotti M, Caporale M, Bajetta E, de Braud F, Mazzaferro V.

Clin Colorectal Cancer. 2017 Sep;16(3):e191-e198. doi: 10.1016/j.clcc.2016.09.007. Epub 2016 Oct 6.

PMID:
27979717
7.

Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.

Spreafico C, Cascella T, Facciorusso A, Sposito C, Rodolfo L, Morosi C, Civelli EM, Vaiani M, Bhoori S, Pellegrinelli A, Marchianò A, Mazzaferro V.

Cardiovasc Intervent Radiol. 2015 Feb;38(1):129-34. doi: 10.1007/s00270-014-0907-0. Epub 2014 May 29.

PMID:
24870698
8.

A retrospective observational analysis to evaluate the off-label use of bevacizumab alone or with irinotecan in recurrent glioblastoma.

Cecchi M, Vaiani M, Ceroti M, Banfi R.

Int J Clin Pharm. 2013 Jun;35(3):483-7. doi: 10.1007/s11096-013-9765-0. Epub 2013 Mar 28.

PMID:
23536107
9.

Triptans in the Italian population: a drug utilization study and a literature review.

Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R.

J Headache Pain. 2008 Apr;9(2):71-6. doi: 10.1007/s10194-008-0020-3. Epub 2008 Mar 4.

10.

Patterns of triptans use: a study based on the records of a community pharmaceutical department.

Pavone E, Banfi R, Vaiani M, Panconesi A.

Cephalalgia. 2007 Sep;27(9):1000-4. Epub 2007 Aug 6.

PMID:
17681022
11.

Heterogeneity in the evaluation of observational studies by Italian ethics committees.

Santarlasci B, Messori A, Pelagotti F, Trippoli S, Vaiani M.

Pharm World Sci. 2005 Feb;27(1):2-3.

PMID:
15861926
12.

Factors influencing the length of hospitalisation in intensive care units: a prospective observational study.

Vacca F, Vaiani M, Messori A, Trippoli S, Maltoni S, Pelaotti F, Santarlasci B, Bardelli F.

Pharm World Sci. 2004 Oct;26(5):263-7.

PMID:
15598066
13.
14.

New drugs for rheumatoid arthritis.

Messori A, Santarlasci B, Vaiani M.

N Engl J Med. 2004 Aug 26;351(9):937-8. No abstract available.

PMID:
15329436
15.

"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.

Messori A, Santarlasci B, Trippoli S, Vaiani M.

BMJ. 2003 Oct 4;327(7418):808-9; discussion 809; author reply 809-10. No abstract available.

16.

Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study.

Trippoli S, Pelagotti F, Messori A, Vacca F, Vaiani M, Maltoni S.

Drugs R D. 2003;4(5):285-91.

PMID:
12952497
17.

Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness.

Messori A, Trippoli S, Vaiani M.

BMJ. 2002 Nov 30;325(7375):1302; author reply 1302. No abstract available.

PMID:
12463189
18.

Antithrombin III in patients admitted to intensive care units: a multicenter observational study.

Messori A, Vacca F, Vaiani M, Trippoli S; Gruppo di Studio sull'antitrombina III.

Crit Care. 2002 Oct;6(5):447-51. Epub 2002 Jul 24.

19.
20.

Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia.

Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A.

Haematologica. 2001 Jul;86(7):722-8.

21.

The cost effectiveness of antiretroviral therapy for HIV disease.

Messori A, Trippoli S, Vaiani M.

N Engl J Med. 2001 Jul 5;345(1):68; author reply 68-9. No abstract available.

PMID:
11439960
22.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

Vaiani M, Trippoli S, Messori A.

N Engl J Med. 2001 Jan 25;344(4):305-6; author reply 306-7. No abstract available.

PMID:
11191660
23.
24.
26.

Cost-effectiveness of irinotecan in advanced colorectal cancer.

Trippoli S, Vaiani M, Cattel F, Messori A.

Ann Oncol. 2000 Jul;11(7):899-900. No abstract available.

PMID:
10997825
27.

Survival gain in cost-effectiveness studies.

Trippoli S, Vaiani M, Messori A, Tendi E.

J Clin Oncol. 2000 Sep 15;18(18):3318. No abstract available.

PMID:
10986065
28.

Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experience.

Bellesi G, Rigacci L, Longo G, Alterini R, Bernardi F, Messori A, Trippoli S, Vaiani M, Carrai V, Rossi Ferrini P.

Oncol Rep. 2000 Jul-Aug;7(4):891-6.

PMID:
10854565

Supplemental Content

Loading ...
Support Center